MESO
Price
$14.69
Change
-$0.34 (-2.26%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.91B
15 days until earnings call
PYPD
Price
$3.23
Change
+$0.01 (+0.31%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
51.19M
2 days until earnings call
Interact to see
Advertisement

MESO vs PYPD

Header iconMESO vs PYPD Comparison
Open Charts MESO vs PYPDBanner chart's image
Mesoblast
Price$14.69
Change-$0.34 (-2.26%)
Volume$2.26K
Capitalization1.91B
PolyPid
Price$3.23
Change+$0.01 (+0.31%)
Volume$449
Capitalization51.19M
MESO vs PYPD Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. PYPD commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Buy and PYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (MESO: $15.03 vs. PYPD: $3.22)
Brand notoriety: MESO and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 42% vs. PYPD: 12%
Market capitalization -- MESO: $1.91B vs. PYPD: $51.35M
MESO [@Biotechnology] is valued at $1.91B. PYPD’s [@Biotechnology] market capitalization is $51.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, MESO is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 5 TA indicator(s) are bullish while PYPD’s TA Score has 3 bullish TA indicator(s).

  • MESO’s TA Score: 5 bullish, 5 bearish.
  • PYPD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MESO is a better buy in the short-term than PYPD.

Price Growth

MESO (@Biotechnology) experienced а -0.92% price change this week, while PYPD (@Biotechnology) price change was -5.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

PYPD is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.91B) has a higher market cap than PYPD($51.2M). PYPD YTD gains are higher at: 5.921 vs. MESO (-24.091). PYPD has higher annual earnings (EBITDA): -29.31M vs. MESO (-77.78M). MESO has more cash in the bank: 37.7M vs. PYPD (8.04M). PYPD has less debt than MESO: PYPD (8.83M) vs MESO (126M). MESO has higher revenues than PYPD: MESO (5.67M) vs PYPD (0).
MESOPYPDMESO / PYPD
Capitalization1.91B51.2M3,732%
EBITDA-77.78M-29.31M265%
Gain YTD-24.0915.921-407%
P/E RatioN/AN/A-
Revenue5.67M0-
Total Cash37.7M8.04M469%
Total Debt126M8.83M1,427%
FUNDAMENTALS RATINGS
MESO: Fundamental Ratings
MESO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MESOPYPD
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 21 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNISF19.00N/A
N/A
Tecnicas Reunidas Sa
KYKOY16.69N/A
N/A
Kyowa Hakko Kogyo Co., Ltd.
OAKC32.00N/A
N/A
Oakworth Capital Inc.
IVCUF9.62N/A
N/A
Investcorp Europe Acquisition Corp I
DWIS0.10-0.01
-11.36%
Dinewise, Inc.

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-1.70%
QTTB - MESO
51%
Loosely correlated
-16.41%
AVTX - MESO
32%
Poorly correlated
+6.95%
ZURA - MESO
30%
Poorly correlated
-4.05%
PRTA - MESO
28%
Poorly correlated
-0.39%
TRAW - MESO
28%
Poorly correlated
+1.35%
More

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.31%
ELEV - PYPD
30%
Poorly correlated
N/A
SER - PYPD
30%
Poorly correlated
+1.10%
MESO - PYPD
29%
Poorly correlated
-1.70%
PRTA - PYPD
24%
Poorly correlated
-0.39%
ASPHF - PYPD
24%
Poorly correlated
N/A
More